Chatham Capital Group, Inc. Pfizer Inc Transaction History
Chatham Capital Group, Inc.
- $595 Million
- Q4 2024
A detailed history of Chatham Capital Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 28,180 shares of PFE stock, worth $739,725. This represents 0.13% of its overall portfolio holdings.
Number of Shares
28,180
Previous 28,664
1.69%
Holding current value
$739,725
Previous $829,000
9.89%
% of portfolio
0.13%
Previous 0.14%
Shares
29 transactions
Others Institutions Holding PFE
# of Institutions
3,368Shares Held
3.69BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.1 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.63 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.08 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA140MShares$3.67 Billion0.7% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $147B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...